The revelation that Family Tree DNA has been working with law enforcement has some worried about a negative impact on the industry.
With ever more data in hand, providers are seeking to enhance their services, providing more detailed ancestry estimates while introducing new offerings around genetic traits and health.
As consumer genomics firms ramp up marketing for Alzheimer's risk tests, one support group says experts should help people understand the results and potential negative effects.
The company said that future health tests it might launch in its store may require features that are only available on version 2 of the Exome+ test.
The app provides results for 15 genetic conditions in the areas of carrier screening, genetic disease risk, medication response, and health-related traits.
The project is informing participants of familial hypercholesterolemia genetic test results, and hereditary breast and ovarian cancer, and Lynch syndrome results will follow.
ADx Healthcare is selling an APOE test on the Helix marketplace, while HealthLytix and Dash Genomics are marketing a polygenic hazard score for late-onset Alzheimer's.
A number of consumer genetic testing companies are adopting best practice guidelines for customer privacy, the Washington Post reports.
The company plans to use the new funding to grow its suite of genomics applications to more than 50 in 2018.
The firm acquired startup HumanCode, which had developed genetic testing apps around ancestry and wellness for the Helix platform.
The World Health Organization has announced the members of its gene-editing committee, according to NPR.
DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.
The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.
In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.